Michele Graham, President of Intel, attended the American Heart Association’s (AHA) Scientific Sessions 2025, November 9-11, in New Orleans to explore how using data and AI to improve patient outcomes is transforming the healthcare landscape. At the forefront of this innovation is our AI platform and database, AnswerY™. This cutting-edge tool analyzes over 82 million real-world, HIPAA-compliant patient-doctor conversations across 155,000+ multispecialty healthcare providers. With regular updates every 30 days, adding approximately 1 million new patient records monthly, AnswerY ensures insights remain fresh, actionable, and impactful in improving patient outcomes.
Hear what Michele had to say when interviewed at the event.
“We’re in the contract sales and medical space, across the life sciences industry. And, what we have really valued over the last decade plus is innovation and data-driven decisions as it impacts healthcare and patient care in particular. So, we’ve invested heavily in an AI database and platform called AnswerY, which brings us in the room between patient and healthcare provider conversations. We’re able to then use that information to draw out insights around why treatment decisions are being made to better impact our patient care decisions as we move forward.”
“Collaboration with the CHTI is really integral to our success and the industry’s success. The American Heart Association (AHA) has really invested heavily in innovation and how that helps advance the overall care of patients and what they get access to.”
“That aligns really well with our vision and being able to really interact with those KOLs, being able to work with and interact with the manufacturers and even some of the patients that are here, and hearing directly from them is really helpful. As we think about, as an industry, what’s necessary to continue to take advances in cardiovascular and cerebrovascular health and really make an impact at the end of the day on how patients are treated.”
Discover how actionable intel from AnswerY can transform cardiovascular and cerebrovascular care. Schedule a demo now.
